Guest guest Posted March 22, 2010 Report Share Posted March 22, 2010 >Paul Scavone <pbscavone >Sun, 21 Mar 2010 17:55:06 -0400 >Gardasil Researcher Speaks Out >gar-lin > > > >Gardasil Researcher Speaks Out > > > >Submitted by ><http://healthfreedoms.org/author/dk/>Drew >Kaplan<http://healthfreedoms.org2010/03/gard.jpg> > >Health Freedom Alliance have been skeptical in >the past about giving young girls the new HPV >vaccine. It now seems we are joined in our >criticism by one of the lead researchers for the >Merck drug who is speaking out about its risks, >benefits and aggressive marketing. > >Dr. Diane Harper says young girls and their >parents should receive more complete warnings >before receiving the vaccine to prevent cervical >cancer. Dr. Harper helped design and carry out >the Phase II and Phase III safety and >effectiveness studies to get Gardasil approved, >and authored many of the published, scholarly >papers about it. She has been a paid speaker and >consultant to Merck. It’s highly unusual for a >researcher to publicly criticize a medicine or >vaccine she helped get approved. Dr. Harper >joins a number of consumer watchdogs, vaccine >safety advocates, and parents who question the >vaccine’s risk-versus-benefit profile. She says >data available for Gardasil shows that it lasts >five years; there is no data showing that it >remains effective beyond five years. This raises >questions about the CDC’s recommendation that >the series of shots be given to girls as young >as 11-years old. “If we vaccinate 11 year olds >and the protection doesn’t last… we’ve put them >at harm from side effects, small but real, for >no benefit,” says Dr. Harper. “The benefit to >public health is nothing, there is no reduction >in cervical cancers, they are just postponed, >unless the protection lasts for at least 15 >years, and over 70% of all sexually active >females of all ages are vaccinated.” She also >says that enough serious side effects have been >reported after Gardasil use that the vaccine >could prove riskier than the cervical cancer it >purports to prevent. Cervical cancer is usually >entirely curable when detected early through normal Pap screenings. > >Dr. Scott Ratner and his wife, who’s also a >physician, expressed similar concerns as Dr. >Harper in an interview with CBS News last year. >One of their teenage daughters became severely >ill after her first dose of Gardasil. Dr. Ratner >says she’d have been better off getting cervical >cancer than the vaccination. “My daughter went >from a varsity lacrosse player at Choate to a >chronically ill, steroid-dependent patient with >autoimmune myofasciitis. I’ve had to ask myself >why I let my eldest of three daughters get an >unproven vaccine against a few strains of a >nonlethal virus that can be dealt with in more effective ways.” > >Merck and the Centers for Disease Control and >Prevention maintain Gardasil is safe and >effective, and that adequate warnings are >provided, cautioning about soreness at the >injection site and risk of fainting after >vaccination. A new study in the Journal of the >American Medical Association found while the >overall risk of side effects appears to be >comparable to other vaccines, Gardasil has a >higher incidence of blood clots reported. Merck >says it continues to have confidence in >Gardasil’s safety profile. Merck also says it’s >looking into cases of ALS, commonly known as Lou >Gehrig’s Disease, reported after vaccination. >ALS is a progressive neurodegenerative disease >that attacks motor neurons in the brain and >spinal cord. Merck and the CDC say there is >currently no evidence that Gardasil caused ALS >in the cases reported. Merck is also monitoring >the number of deaths reported after Gardasil: at >least 32. Merck and CDC says it’s unclear >whether the deaths were related to the vaccine, >and that just because patients died after the >shots doesn’t mean the shots were necessarily to blame. > >According to Dr. Harper, assessing the true >adverse event risk of Gardasil, and comparing it >to the risk of cervical cancer can be tricky and >complex. “The number of women who die from >cervical cancer in the US every year is small >but real. It is small because of the success of the Pap screening program.” > >“The risks of serious adverse events including >death reported after Gardasil use in (the JAMA >article by CDC’s Dr. Barbara Slade) were >3.4/100,000 doses distributed. The rate of >serious adverse events on par with the death >rate of cervical cancer. Gardasil has been >associated with at least as many serious adverse >events as there are deaths from cervical cancer >developing each year. Indeed, the risks of >vaccination are underreported in Slade’s >article, as they are based on a denominator of >doses distributed from Merck’s warehouse. Up to >a third of those doses may be in refrigerators >waiting to be dispensed as the autumn onslaught >of vaccine messages is sent home to parents the >first day of school. Should the denominator in >Dr. Slade’s work be adjusted to account for >this, and then divided by three for the number >of women who would receive all three doses, the >incidence rate of serious adverse events >increases up to five fold. How does a parent >value that information,” said Harper. > >Dr. Harper agrees with Merck and the CDC that >Gardasil is safe for most girls and women. But >she says the side effects reported so far call >for more complete disclosure to patients. She >says they should be told that protection from >the vaccination might not last long enough to >provide a cancer protection benefit, and that >its risks – “small but real” – could occur more >often than the cervical cancer itself would. > >“Parents and women must know that deaths >occurred. Not all deaths that have been reported >were represented in Dr. Slade’s work, one-third >of the death reports were unavailable to the >CDC, leaving the parents of the deceased >teenagers in despair that the CDC is ignoring >the very rare but real occurrences that need not >have happened if parents were given information >stating that there are real, but small risks of >death surrounding the administration of Gardasil.” > >She also worries that Merck’s aggressive >marketing of the vaccine may have given women a >false sense of security. “The future >expectations women hold because they have >received free doses of Gardasil purchased by >philanthropic foundations, by public health >agencies or covered by insurance is the true >threat to cervical cancer in the future. Should >women stop Pap screening after vaccination, the >cervical cancer rate will actually increase per >year. Should women believe this is preventive >for all cancers – something never stated, but >often inferred by many in the population– a >reduction in all health care will compound our >current health crisis. Should Gardasil not be >effective for more than 15 years, the most >costly public health experiment in cancer control will have failed miserably.” > >CDC continues to recommend Gardasil for girls >and young women. The agency says the vaccine’s >benefits outweigh its risks and that it is an >important tool in fighting a serious cancer. > >Dr. Harper says the risk-benefit analysis for >Gardasil in other countries may shape up >differently than what she believes is true in >the US. “Of course, in developing countries >where there is no safety Pap screening for women >repeatedly over their lifetimes, the risks of >serious adverse events may be acceptable as the >incidence rate of cervical cancer is five to 12 >times higher than in the US, dwarfing the risk >of death reported after Gardasil.” > ><http://www.cbsnews.com/stories/2009/08/19/cbsnews_investigates/main5253431.sht\ ml>http://www.cbsnews.com/stories/2009/08/19/cbsnews_investigates/main5253431.sh\ tml > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.